Evidence map›Paper›PMID 27977393›Full record

ReviewHypertension (Dallas, Tex. : 1979)2016

Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association.

Costantino Iadecola, Kristine Yaffe, José Biller, Lisa C Bratzke, Frank M Faraci, Philip B Gorelick, Martha Gulati, Hooman Kamel, David S Knopman, Lenore J Launer and 4 more

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Hypertension (Dallas, Tex. : 1979), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04278911 (Effect of Cognitive Impairment), which is not on this map. Cited by 378 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
378citing papers in PubMed, 10 pooled it
46.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04278911 unknown statusnot on this mapstarted 2020, after this paper: background citation

Effect of Cognitive Impairment (CI) on Prognosis in the Elderly Patients With Acute Coronary Syndrome (ACS)

TypeobservationalSponsorBeijing Friendship HospitalRan2020 to 2022Enrolled500ConditionsAcute Coronary Syndrome, Cognitive Impairment, ElderlyArmsMMSE and MoCA
3 · Its place in the literature

Who cites it

378 citing papers in PubMed, 10 syntheses or guidelines pooled it, 710 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. The Correlation between Two Angiotensin-Converting Enzyme Inhibitor's Concentrations and Cognition.International journal of environmental research and public health · 2022
    Trial
  15. Trial
  16. Trial
  17. Article
  18. Article
  19. Hypertension acts together with Aβ pathology in late-life to promote memory loss.The journal of prevention of Alzheimer's disease · 2026
    Article
  20. Article

318 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Costantino Iadecola
Kristine Yaffe
José Biller
Lisa C Bratzke
Frank M Faraci
Philip B Gorelick
Martha Gulati
Hooman Kamel
David S Knopman
Lenore J Launer
Jane S Saczynski
Sudha Seshadri
Adina Zeki Al Hazzouri
American Heart Association Council on Hypertension; Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Stroke Council
St.Martha's College Of Nursing · INW. L. Gore & Associates (Germany) · DE

Funding

UC Davis Alzheimer's Disease Core CenterP30AG010129 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI DECARLI, CHARLES · 1991 to 2020
$28.3M
PRECURSORS OF STROKE INCIDENCE AND PROGNOSISR01NS017950 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Hugo Javier Aparicio, Jose Rafael Romero · 1985 to 2026
$22.9M
Hypertension and neurovascular dysfunctionR37NS089323 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IADECOLA, COSTANTINO · 2015 to 2021
$3.1M
Lifecourse cardiovascular risk, depression and cognition in black & white adultsK01AG047273 · NIA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ZEKI AL HAZZOURI, ADINA · 2014 to 2018
$617k
NIA NIH HHS K01 AG047273NIA NIH HHS P30 AG010129NINDS NIH HHS R01 NS017950NINDS NIH HHS R37 NS089323
6 · The paper itself

Abstract

backgroundAge-related dementia, most commonly caused by Alzheimer disease or cerebrovascular factors (vascular dementia), is a major public health threat. Chronic arterial hypertension is a well-established risk factor for both types of dementia, but the link between hypertension and its treatment and cognition remains poorly understood. In this scientific statement, a multidisciplinary team of experts examines the impact of hypertension on cognition to assess the state of the knowledge, to identify gaps, and to provide future directions.

methodsAuthors with relevant expertise were selected to contribute to this statement in accordance with the American Heart Association conflict-of-interest management policy. Panel members were assigned topics relevant to their areas of expertise, reviewed the literature, and summarized the available data.

resultsHypertension disrupts the structure and function of cerebral blood vessels, leads to ischemic damage of white matter regions critical for cognitive function, and may promote Alzheimer pathology. There is strong evidence of a deleterious influence of midlife hypertension on late-life cognitive function, but the cognitive impact of late-life hypertension is less clear. Observational studies demonstrated a cumulative effect of hypertension on cerebrovascular damage, but evidence from clinical trials that antihypertensive treatment improves cognition is not conclusive.

conclusionsAfter carefully reviewing the literature, the group concluded that there were insufficient data to make evidence-based recommendations. However, judicious treatment of hypertension, taking into account goals of care and individual characteristics (eg, age and comorbidities), seems justified to safeguard vascular health and, as a consequence, brain health.

Indexed as

Practice Guidelines as TopicAgedAged, 80 and overAge FactorsAlzheimer DiseaseAmerican Heart AssociationAntihypertensive AgentsCognition DisordersDementia, VascularDisease ProgressionEvidence-Based MedicineFemaleFollow-Up StudiesHumansHypertensionMaleAntihypertensive AgentsAHA Scientific StatementsAlzheimer diseasebiomarkersblood pressureclinical trialsneuroimagingtherapyvascular cognitive impairment

Identifiers

PMID27977393
PMCPMC5361411
OpenAlexW2530115453

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.